---
input_text: '[Tuberous sclerosis complex: diagnosis and current treatment]. Tuberous
  sclerosis complex is an autosomal dominant genetic multisystemic disorder caused
  primarily by mutations in one of the two tumor suppressor genes TSC1 or TSC2, resulting
  in increased activation of the mTOR pathway. Regarding clinical manifestations,
  a wide range of phenotypic variability exists, with symptoms constellations that
  may differ in affected organs (brain, skin, heart, eyes, kidneys, lungs), age of
  presentation and severity, but usually with great impact in biopsychosocial aspects
  of health and in quality of life. Main clinical neurological features are epilepsy
  (frequently, antiepileptic drug-resistant epilepsy), neuropsychiatric disorders,
  and subependymal giant cell astrocytomas. Recently, many therapeutic strategies
  have developed, including preventive treatment of epilepsy, new options for treatment
  of epilepsy as cannabidiol, mTOR inhibitors, ketogenic diet, and a more precise
  epilepsy surgery. Subependymal giant cell astrocytomas may require surgical procedures
  or mTOR inhibitors treatment. mTOR inhibitors may also be useful for other comorbidities.
  To improve quality of life of patients with tuberous sclerosis complex, it is essential
  to be able to deliver an integrated approach by specialized multidisciplinary teams,
  coordinated with primary care physicians and health professionals, that include
  access to treatments, attention of psychosocial aspects, and an adequate health
  care transition from pediatric to adult care.'
raw_completion_output: |-
  primary_disease: Tuberous sclerosis complex
  medical_actions: Preventive treatment of epilepsy; Treatment of epilepsy with cannabidiol; mTOR inhibitors; Ketogenic diet; Epilepsy surgery; Surgical procedures for subependymal giant cell astrocytomas
  symptoms: Epilepsy; Antiepileptic drug-resistant epilepsy; Neuropsychiatric disorders; Subependymal giant cell astrocytomas
  chemicals: Cannabidiol; mTOR inhibitors
  action_annotation_relationships: Preventive treatment of epilepsy PREVENTS Epilepsy IN Tuberous sclerosis complex; Treatment of epilepsy with cannabidiol (Cannabidiol) TREATS Antiepileptic drug-resistant epilepsy IN Tuberous sclerosis complex; mTOR inhibitors TREATS Subependymal giant cell astrocytomas IN Tuberous sclerosis complex; Ketogenic diet TREATS Epilepsy IN Tuberous sclerosis complex; Epilepsy surgery TREATS Epilepsy IN Tuberous sclerosis complex; Surgical procedures for subependymal giant cell astrocytomas TREATS Subependymal giant cell astrocytomas IN Tuberous sclerosis complex
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Surgical procedures for subependymal giant cell astrocytomas TREATS Subependymal giant cell astrocytomas IN Tuberous sclerosis complex

  ===

extracted_object:
  primary_disease: MONDO:0001734
  medical_actions:
    - Preventive treatment of epilepsy
    - Treatment of epilepsy with cannabidiol
    - mTOR inhibitors
    - Ketogenic diet
    - Epilepsy surgery
    - Surgical procedures for subependymal giant cell astrocytomas
  symptoms:
    - HP:0001250
    - Antiepileptic drug-resistant epilepsy
    - Neuropsychiatric disorders
    - HP:0009718
  chemicals:
    - CHEBI:69478
    - CHEBI:68481
  action_annotation_relationships:
    - subject: Preventive treatment of epilepsy
      predicate: PREVENTS
      object: HP:0001250
      qualifier: MONDO:0001734
    - subject: Treatment of epilepsy
      predicate: TREATS
      object: Antiepileptic drug-resistant epilepsy
      qualifier: MONDO:0001734
      subject_extension: CHEBI:69478
    - subject: mTOR inhibitors
      predicate: TREATS
      object: HP:0009718
      qualifier: MONDO:0001734
      subject_extension: CHEBI:68481
    - subject: Ketogenic diet
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0001734
      subject_extension: Ketogenic diet
    - subject: Epilepsy surgery
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0001734
    - subject: <Surgical procedures>
      predicate: <TREATS>
      object: <Subependymal giant cell astrocytomas>
      qualifier: <Tuberous sclerosis complex>
      subject_qualifier: <Not applicable>
      object_qualifier: <Not applicable>
      subject_extension: <Not applicable>
      object_extension: <Not applicable>
named_entities:
  - id: MONDO:0016693
    label: Subependymal giant cell astrocytoma
  - id: MAXO:0000447
    label: Surgical removal
  - id: CHEBI:68478
    label: everolimus
  - id: MONDO:0005550
    label: Intellectual disability (ID)
  - id: HP:0001249
    label: Intellectual disability (ID)
  - id: HP:0001250
    label: seizures
  - id: HP:0011097
    label: epileptic spasms
  - id: HP:0002121
    label: absence seizures
  - id: CHEBI:69478
    label: cannabidiol (CBD)
  - id: MONDO:0001734
    label: Tuberous Sclerosis Complex
  - id: MAXO:0001065
    label: Nephrectomy
  - id: MAXO:0000602
    label: Hemodialysis
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: MAXO:0000600
    label: Renal replacement therapy
  - id: HP:0006772
    label: Angiomyolipomas
  - id: HP:0005584
    label: Renal cell carcinoma
  - id: HP:0001892
    label: Bleeding tendency
  - id: HP:0000083
    label: Renal insufficiency
  - id: HP:0003774
    label: end-stage renal failure
  - id: CHEBI:68481
    label: Mammalian target of rapamycin inhibitor
  - id: CHEBI:63638
    label: Vigabatrin
  - id: MONDO:0100062
    label: Infantile-Onset Developmental and Epileptic Encephalopathies (DEE)
  - id: CHEBI:26708
    label: Sodium
  - id: CHEBI:26216
    label: Potassium
  - id: MONDO:0005027
    label: epilepsy
  - id: MAXO:0000942
    label: vagus nerve stimulation (VNS)
  - id: HP:0004808
    label: multiple bilateral angiomyolipoma (AMLs)
  - id: CHEBI:9168
    label: sirolimus
  - id: HP:0001263
    label: Developmental delay
  - id: CHEBI:17234
    label: Glucose
  - id: CHEBI:15756
    label: Fatty acid (palmitate)
  - id: MONDO:0010979
    label: Tuberous sclerosis (TS); Diffuse large B-cell lymphoma (DLBCL)
  - id: CHEBI:8382
    label: Prednisone
  - id: CHEBI:480999
    label: Vinorelbine
  - id: CHEBI:4911
    label: Etoposide
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:64357
    label: Rituximab
  - id: CHEBI:76612
    label: Ibrutinib
  - id: MAXO:0000647
    label: chemotherapy
  - id: MONDO:0007254
    label: Breast Cancer
  - id: CHEBI:85993
    label: Palbociclib
  - id: CHEBI:31638
    label: Fulvestrant
  - id: CHEBI:41774
    label: Tamoxifen
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:8228
    label: Pioglitazone
  - id: HP:0006536
    label: Airway obstruction
  - id: HP:0000822
    label: High blood pressure
  - id: CHEBI:6367
    label: lamotrigine
  - id: CHEBI:60654
    label: valproate
  - id: CHEBI:6437
    label: levetiracetam
  - id: HP:0003394
    label: Spasms
  - id: CHEBI:24621
    label: Hormone
  - id: CHEBI:3892
    label: Adrenocorticotropic hormone (ACTH)
  - id: CHEBI:8378
    label: Prednisolone
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MAXO:0001064
    label: Mastectomy
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0031111
    label: Skin hamartoma
  - id: MONDO:0004691
    label: Autosomal dominant polycystic kidney disease
  - id: HP:0009718
    label: Subependymal giant cell astrocytomas
